[S02DA03, antipyrine, The risk or severity of bleeding can be increased when Antipyrine is combined with Clopidogrel.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Clopidogrel is combined with Streptokinase.]
[L01AD04, streptozocin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Streptozocin.]
[J01EC02, sulfadiazine, The metabolism of Sulfadiazine can be decreased when combined with Clopidogrel.]
[S01AB01, sulfamethizole, The metabolism of Clopidogrel can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Sulfamethoxazole can be decreased when combined with Clopidogrel.]
[J01EC03, sulfamoxole, The metabolism of Clopidogrel can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Clopidogrel can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Clopidogrel can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Clopidogrel can be decreased when combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of bleeding can be increased when Sulindac is combined with Clopidogrel.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Clopidogrel.]
[M01AX04, apazone, The risk or severity of bleeding can be increased when Azapropazone is combined with Clopidogrel.]
[L01BB02, mercaptopurine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Mercaptopurine.]
[N06DA01, tacrine, The metabolism of Clopidogrel can be decreased when combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Clopidogrel.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Clopidogrel.]
[B01AE07, dabigatran etexilate, Clopidogrel may increase the anticoagulant activities of Dabigatran etexilate.]
[G03BA03, testosterone, The metabolism of Clopidogrel can be decreased when combined with Testosterone.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Clopidogrel.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Clopidogrel.]
[L04AX02, thalidomide, The metabolism of Clopidogrel can be increased when combined with Thalidomide.]
[R03DA07, theobromine, The metabolism of Theobromine can be decreased when combined with Clopidogrel.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Clopidogrel.]
[P02CA02, thiabendazole, The metabolism of Clopidogrel can be decreased when combined with Thiabendazole.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Thiamine.]
[L01XX41, eribulin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Eribulin.]
[L01AC01, thiotepa, The metabolism of Clopidogrel can be decreased when combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Tioguanine.]
[N05CA19, thiopental, The metabolism of Clopidogrel can be decreased when combined with Thiopental.]
[N05AC02, thioridazine, The metabolism of Clopidogrel can be decreased when combined with Thioridazine.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Clopidogrel.]
[B01AC05, ticlopidine, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Ticlopidine resulting in a loss in efficacy.]
[N02AX01, tilidine, Tilidine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01ED01, timolol, The metabolism of Clopidogrel can be decreased when combined with Timolol.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Clopidogrel.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Clopidogrel.]
[M02AA21, tolmetin, The risk or severity of bleeding can be increased when Tolmetin is combined with Clopidogrel.]
[N02AX02, tramadol, Tramadol can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AF04, tranylcypromine, The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Clopidogrel.]
[C01DX11, trapidil, Clopidogrel may increase the antiplatelet activities of Trapidil.]
[N06AX05, trazodone, The risk or severity of bleeding can be increased when Trazodone is combined with Clopidogrel.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Clopidogrel.]
[S01BA05, triamcinolone, The metabolism of Clopidogrel can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The metabolism of Clopidogrel can be decreased when combined with Triamterene.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Clopidogrel.]
[N05AB06, trifluoperazine, The metabolism of Trifluoperazine can be decreased when combined with Clopidogrel.]
[R03BA07, mometasone, The metabolism of Clopidogrel can be increased when combined with Mometasone.]
[A03AA05, trimebutine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Trimebutine.]
[N03AC02, trimethadione, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Trimethadione.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be decreased when combined with Clopidogrel.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Clopidogrel.]
[J01FA08, troleandomycin, The metabolism of Clopidogrel can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Clopidogrel.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Tubocurarine.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Clopidogrel.]
[L02BX03, abiraterone, The serum concentration of Clopidogrel can be increased when it is combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Clopidogrel can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Clopidogrel can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Clopidogrel can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Clopidogrel can be decreased when combined with Rilpivirine.]
[B01AD04, urokinase, Clopidogrel may increase the anticoagulant activities of Urokinase.]
[B01AF01, rivaroxaban, Clopidogrel may increase the anticoagulant activities of Rivaroxaban.]
[B01AC24, ticagrelor, The risk or severity of bleeding can be increased when Clopidogrel is combined with Ticagrelor.]
[C08DA01, verapamil, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Verapamil.]
[N06AX09, viloxazine, The metabolism of Clopidogrel can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Vinblastine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Clopidogrel.]
[L01CA03, vindesine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Vindesine.]
[A11HA03, vitamin E, Vitamin E may increase the antiplatelet activities of Clopidogrel.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Warfarin.]
[J05AF01, zidovudine, The metabolism of Zidovudine can be decreased when combined with Clopidogrel.]
[J05AE02, indinavir, The metabolism of Clopidogrel can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Clopidogrel can be increased when it is combined with Vemurafenib.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Clopidogrel.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Lepirudin.]
[R03DC01, zafirlukast, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Zafirlukast resulting in a loss in efficacy.]
[A02BC04, rabeprazole, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Rabeprazole resulting in a loss in efficacy.]
[J01MA13, trovafloxacin, The metabolism of Clopidogrel can be decreased when combined with Trovafloxacin.]
[N05AE04, ziprasidone, The metabolism of Clopidogrel can be decreased when combined with Ziprasidone.]
[L04AA34, alemtuzumab, The risk or severity of bleeding can be increased when Clopidogrel is combined with Alemtuzumab.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Clopidogrel.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Clopidogrel.]
[L03AB11, peginterferon alfa-2a, The metabolism of Clopidogrel can be decreased when combined with Peginterferon alfa-2a.]
[L01FA01, rituximab, The risk or severity of bleeding can be increased when Clopidogrel is combined with Rituximab.]
[J02AC03, voriconazole, The metabolism of Clopidogrel can be decreased when combined with Voriconazole.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Clopidogrel.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Clopidogrel.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Clopidogrel.]
[H02AB11, prednylidene, The metabolism of Clopidogrel can be increased when combined with Prednylidene.]
[L01BC07, azacitidine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Azacitidine.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Clopidogrel.]
[L01BC05, gemcitabine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Gemcitabine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Clopidogrel.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Gemtuzumab ozogamicin.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Clopidogrel.]
[L01XG02, carfilzomib, The risk or severity of bleeding can be increased when Clopidogrel is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Clopidogrel can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Clopidogrel can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Clopidogrel.]
[L01EA04, bosutinib, The risk or severity of bleeding can be increased when Clopidogrel is combined with Bosutinib.]
[L04AA31, teriflunomide, The serum concentration of Clopidogrel can be decreased when it is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Clopidogrel is combined with Defibrotide.]
[L01EX05, regorafenib, The metabolism of Clopidogrel can be decreased when combined with Regorafenib.]
[N05CA04, barbital, The metabolism of Barbital can be decreased when combined with Clopidogrel.]
[J05AE04, nelfinavir, The metabolism of Clopidogrel can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be decreased when combined with Clopidogrel.]
[N04BD02, rasagiline, The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Clopidogrel.]
[C08CA13, lercanidipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Lercanidipine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Clopidogrel.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Clopidogrel.]
[L04AA29, tofacitinib, The risk or severity of bleeding can be increased when Clopidogrel is combined with Tofacitinib.]
[N02CC03, zolmitriptan, The metabolism of Clopidogrel can be decreased when combined with Zolmitriptan.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Clopidogrel.]
[G04BE03, sildenafil, The metabolism of Clopidogrel can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Clopidogrel.]
[B01AF02, apixaban, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Apixaban.]
[C04AX11, bencyclane, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Bencyclane.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Clopidogrel.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Clopidogrel.]
[N02BA10, benorilate, The risk or severity of bleeding can be increased when Benorilate is combined with Clopidogrel.]
[J01MA15, gemifloxacin, The metabolism of Clopidogrel can be decreased when combined with Gemifloxacin.]
[M04AB03, benzbromarone, The metabolism of Clopidogrel can be decreased when combined with Benzbromarone.]
[S01AE07, moxifloxacin, The metabolism of Clopidogrel can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, The metabolism of Clopidogrel can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Clopidogrel.]
[M01AH01, celecoxib, The risk or severity of bleeding can be increased when Celecoxib is combined with Clopidogrel.]
[L04AA18, everolimus, The risk or severity of bleeding can be increased when Clopidogrel is combined with Everolimus.]
[L01EC02, dabrafenib, The serum concentration of Clopidogrel can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of bleeding can be increased when Benzydamine is combined with Clopidogrel.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Clopidogrel.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Clopidogrel.]
[C08EA02, bepridil, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Bepridil.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Clopidogrel.]
[A05AA03, cholic acid, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Cholic Acid.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Ibrutinib is combined with Clopidogrel.]
[N06AX26, vortioxetine, The risk or severity of bleeding can be increased when Vortioxetine is combined with Clopidogrel.]
[N03AF04, eslicarbazepine, The metabolism of Clopidogrel can be decreased when combined with Eslicarbazepine.]
[D01AC18, luliconazole, The serum concentration of Clopidogrel can be increased when it is combined with Luliconazole.]
[J05AP05, simeprevir, The metabolism of Clopidogrel can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The metabolism of Clopidogrel can be decreased when combined with Dapagliflozin.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Clopidogrel.]
[A16AA07, metreleptin, The metabolism of Clopidogrel can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Clopidogrel can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The metabolism of Clopidogrel can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Clopidogrel can be decreased when combined with Betaxolol.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Clopidogrel is combined with Argatroban.]
[L04AC11, siltuximab, The metabolism of Clopidogrel can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Clopidogrel can be decreased when combined with Ceritinib.]
[B01AC26, vorapaxar, The risk or severity of bleeding can be increased when Clopidogrel is combined with Vorapaxar.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Clopidogrel is combined with Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of bleeding can be increased when Clopidogrel is combined with Belinostat.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Clopidogrel.]
[L03AB13, peginterferon beta-1a, The risk or severity of bleeding can be increased when Clopidogrel is combined with Peginterferon beta-1a.]
[J01XA05, oritavancin, The metabolism of Clopidogrel can be decreased when combined with Oritavancin.]
[A06AH03, naloxegol, Naloxegol can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01BC08, decitabine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Decitabine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Clopidogrel.]
[S03AA06, gentamicin, The serum concentration of Gentamicin can be increased when it is combined with Clopidogrel.]
[L01FX07, blinatumomab, The risk or severity of bleeding can be increased when Clopidogrel is combined with Blinatumomab.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Clopidogrel.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Clopidogrel.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Clopidogrel is combined with Dicoumarol.]
[B01AF03, edoxaban, The risk or severity of bleeding can be increased when Clopidogrel is combined with Edoxaban.]
[N06AX11, mirtazapine, The metabolism of Clopidogrel can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Clopidogrel can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of bleeding can be increased when Clopidogrel is combined with Palbociclib.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Clopidogrel.]
[N02BE01, acetaminophen, The metabolism of Clopidogrel can be decreased when combined with Acetaminophen.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Clopidogrel is combined with Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Clopidogrel.]
[A07DA06, eluxadoline, Eluxadoline can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B01AC25, cangrelor, Cangrelor may decrease the antiplatelet activities of Clopidogrel.]
[M02AA25, aceclofenac, The risk or severity of bleeding can be increased when Aceclofenac is combined with Clopidogrel.]
[M01AB11, acemetacin, The risk or severity of bleeding can be increased when Acemetacin is combined with Clopidogrel.]
[A02BC03, lansoprazole, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Lansoprazole resulting in a loss in efficacy.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Clopidogrel.]
[J02AC05, isavuconazole, The metabolism of Clopidogrel can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Clopidogrel can be decreased when it is combined with Osimertinib.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Clopidogrel.]
[A10BB31, acetohexamide, The metabolism of Acetohexamide can be decreased when combined with Clopidogrel.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Clopidogrel.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Clopidogrel.]
[M01AE16, alminoprofen, The risk or severity of bleeding can be increased when Alminoprofen is combined with Clopidogrel.]
[N02BA02, aloxiprin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Aloxiprin.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Clopidogrel.]
[L01XX52, venetoclax, The metabolism of Clopidogrel can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be decreased when combined with Clopidogrel.]
[R06AB01, brompheniramine, The metabolism of Brompheniramine can be decreased when combined with Clopidogrel.]
[C08CA01, amlodipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Amlodipine.]
[A05AA04, obeticholic acid, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Obeticholic acid.]
[N01BB01, bupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Clopidogrel.]
[N07BC01, buprenorphine, Buprenorphine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05BE01, buspirone, The metabolism of Clopidogrel can be decreased when combined with Buspirone.]
[L01AB01, busulfan, The risk or severity of bleeding can be increased when Clopidogrel is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of bleeding can be increased when Clopidogrel is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Clopidogrel.]
[M02AA03, clofezone, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Rabeprazole resulting in a loss in efficacy.]
[N02AF01, butorphanol, Butorphanol can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Clopidogrel.]
[L01XK03, rucaparib, The metabolism of Clopidogrel can be decreased when combined with Rucaparib.]
[L01EF02, ribociclib, The metabolism of Clopidogrel can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of bleeding can be increased when Balsalazide is combined with Clopidogrel.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Clopidogrel.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Clopidogrel.]
[N06BC01, caffeine, The metabolism of Clopidogrel can be decreased when combined with Caffeine.]
[J01XX08, linezolid, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Clopidogrel.]
[J05AE09, tipranavir, Tipranavir may increase the antiplatelet activities of Clopidogrel.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Clopidogrel.]
[L04AB02, infliximab, The metabolism of Clopidogrel can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Clopidogrel can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Clopidogrel.]
[N04BD03, safinamide, The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Clopidogrel.]
[J01MA23, delafloxacin, The metabolism of Clopidogrel can be increased when combined with Delafloxacin.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Clopidogrel is combined with Betrixaban.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Acetylcholine.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Clopidogrel.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Clopidogrel.]
[L01XH01, vorinostat, The risk or severity of bleeding can be increased when Clopidogrel is combined with Vorinostat.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Clopidogrel.]
[J05AG03, efavirenz, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Efavirenz resulting in a loss in efficacy.]
[L01BA03, raltitrexed, The risk or severity of bleeding can be increased when Clopidogrel is combined with Raltitrexed.]
[R03BA02, budesonide, The metabolism of Clopidogrel can be increased when combined with Budesonide.]
[C04AX20, buflomedil, Clopidogrel may increase the antiplatelet activities of Buflomedil.]
[M01AB07, bumadizone, The risk or severity of bleeding can be increased when Bumadizone is combined with Clopidogrel.]
[L01EL02, acalabrutinib, The metabolism of Clopidogrel can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Clopidogrel can be decreased when combined with Letermovir.]
[N01BX04, capsaicin, The metabolism of Clopidogrel can be increased when combined with Capsaicin.]
[L02BB05, apalutamide, The serum concentration of Apalutamide can be increased when it is combined with Clopidogrel.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Clopidogrel.]
[L03AB06, interferon alfa-n1, The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-n1.]
[C07AG02, carvedilol, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Carvedilol.]
[N03AX24, cannabidiol, The metabolism of Clopidogrel can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Clopidogrel can be increased when combined with Avatrombopag.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Clopidogrel.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Clopidogrel.]
[L01XX62, ivosidenib, The metabolism of Clopidogrel can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Clopidogrel can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Clopidogrel can be decreased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Clopidogrel.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Clopidogrel.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Clopidogrel.]
[M01AC05, lornoxicam, The risk or severity of bleeding can be increased when Lornoxicam is combined with Clopidogrel.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Clopidogrel.]
[M03BA02, carisoprodol, The metabolism of Clopidogrel can be decreased when combined with Carisoprodol.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Clopidogrel.]
[L04AA39, emapalumab, The metabolism of Clopidogrel can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Clopidogrel can be decreased when combined with Carmustine.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Clopidogrel.]
[B01AX07, caplacizumab, Clopidogrel may increase the antiplatelet activities of Caplacizumab.]
[B01AC23, cilostazol, Clopidogrel may increase the antiplatelet activities of Cilostazol.]
[P02BX04, triclabendazole, The metabolism of Clopidogrel can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Clopidogrel.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Clopidogrel.]
[J01FA09, clarithromycin, The metabolism of Clopidogrel can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The serum concentration of Solriamfetol can be increased when it is combined with Clopidogrel.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Clopidogrel.]
[N05BA09, clobazam, The metabolism of Clopidogrel can be decreased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Clopidogrel can be increased when combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Candesartan can be decreased when combined with Clopidogrel.]
[L04AB01, etanercept, The metabolism of Clopidogrel can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Clopidogrel can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Clopidogrel can be decreased when it is combined with Alpelisib.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Clopidogrel.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Clopidogrel.]
[N07XX11, pitolisant, The serum concentration of Clopidogrel can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Clopidogrel.]
[A10AE03, insulin, regular, pork, The metabolism of Clopidogrel can be increased when combined with Insulin pork.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Clopidogrel.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Clopidogrel.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Clopidogrel.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Clopidogrel.]
[N03AX25, cenobamate, The serum concentration of Clopidogrel can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Clopidogrel can be increased when it is combined with Givosiran.]
[N02AX03, dezocine, Dezocine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Clopidogrel.]
[N05CM21, lemborexant, The serum concentration of Clopidogrel can be decreased when it is combined with Lemborexant.]
[M01AX21, diacetylrhein, The metabolism of Clopidogrel can be decreased when combined with Diacerein.]
[S01AE06, gatifloxacin, The metabolism of Clopidogrel can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Clopidogrel can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Clopidogrel can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Clopidogrel.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Clopidogrel.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Clopidogrel.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Clopidogrel.]
[N02AA08, dihydrocodeine, Dihydrocodeine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Clopidogrel.]
[M01AH02, rofecoxib, The risk or severity of bleeding can be increased when Rofecoxib is combined with Clopidogrel.]
[L01XF03, bexarotene, The metabolism of Bexarotene can be decreased when combined with Clopidogrel.]
[C08CA16, clevidipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Clopidogrel.]
[L01AA02, chlorambucil, The risk or severity of bleeding can be increased when Clopidogrel is combined with Chlorambucil.]
[S03AA08, chloramphenicol, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Chloramphenicol resulting in a loss in efficacy.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Clopidogrel.]
[L01EX17, capmatinib, The metabolism of Clopidogrel can be decreased when combined with Capmatinib.]
[D07XB03, fluprednidene, The metabolism of Clopidogrel can be increased when combined with Fluprednidene.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be decreased when combined with Clopidogrel.]
[M01AC04, droxicam, The risk or severity of bleeding can be increased when Droxicam is combined with Clopidogrel.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Lepirudin.]
[M02AA27, dexketoprofen, The risk or severity of bleeding can be increased when Dexketoprofen is combined with Clopidogrel.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Clopidogrel.]
[C08CA17, levamlodipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Levamlodipine.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Clopidogrel.]
[L04AC19, satralizumab, The serum concentration of Clopidogrel can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, Oliceridine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Clopidogrel.]
[L01EX23, pralsetinib, The metabolism of Clopidogrel can be decreased when combined with Pralsetinib.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Clopidogrel.]
[N05AA01, chlorpromazine, The metabolism of Clopidogrel can be decreased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Clopidogrel.]
[M03BB03, chlorzoxazone, The metabolism of Clopidogrel can be decreased when combined with Chlorzoxazone.]
[N02BA07, ethenzamide, The risk or severity of bleeding can be increased when Ethenzamide is combined with Clopidogrel.]
[N02BA03, choline salicylate, The risk or severity of bleeding can be increased when Clopidogrel is combined with Choline salicylate.]
[N06BX18, vinpocetine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Vinpocetine.]
[M01AB08, etodolac, The risk or severity of bleeding can be increased when Etodolac is combined with Clopidogrel.]
[M02AA06, etofenamate, The risk or severity of bleeding can be increased when Etofenamate is combined with Clopidogrel.]
[B06AC06, berotralstat, The metabolism of Clopidogrel can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The serum concentration of Lonafarnib can be increased when it is combined with Clopidogrel.]
[L01BB05, fludarabine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Fludarabine.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Clopidogrel.]
[P03AX07, abametapir, The serum concentration of Clopidogrel can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The metabolism of Clopidogrel can be decreased when combined with Tepotinib.]
[V03AF12, trilaciclib, The metabolism of Clopidogrel can be increased when combined with Trilaciclib.]
[N03AX10, felbamate, The metabolism of Clopidogrel can be decreased when combined with Felbamate.]
[M01AE05, fenbufen, The risk or severity of bleeding can be increased when Fenbufen is combined with Clopidogrel.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Clopidogrel.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Clopidogrel.]
[J01MB07, flumequine, The metabolism of Clopidogrel can be decreased when combined with Flumequine.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Clopidogrel.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Clopidogrel.]
[L03AB10, peginterferon alfa-2b, The serum concentration of Clopidogrel can be increased when it is combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Clopidogrel can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Cinnarizine.]
[J01MB06, cinoxacin, The metabolism of Clopidogrel can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Clopidogrel can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Clopidogrel can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The serum concentration of Cisplatin can be increased when it is combined with Clopidogrel.]
[N06AB04, citalopram, The risk or severity of hemorrhage can be increased when Citalopram is combined with Clopidogrel.]
[H01AC07, somapacitan, The metabolism of Clopidogrel can be decreased when combined with Somapacitan.]
[C03DA05, finerenone, The metabolism of Finerenone can be decreased when combined with Clopidogrel.]
[P01CA03, fexinidazole, The metabolism of Clopidogrel can be decreased when combined with Fexinidazole.]
[L01XX74, belzutifan, The metabolism of Belzutifan can be decreased when combined with Clopidogrel.]
[H01AC09, lonapegsomatropin, The metabolism of Clopidogrel can be increased when combined with Lonapegsomatropin.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Clopidogrel.]
[A10BB12, glimepiride, The metabolism of Glimepiride can be decreased when combined with Clopidogrel.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Clopidogrel.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Clopidogrel.]
[N06AX25, St. John's wort extract, The metabolism of Clopidogrel can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Clopidogrel can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Clopidogrel can be decreased when combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The risk or severity of bleeding and thrombocytopenia can be increased when Clopidogrel is combined with Abrocitinib.]
[J04BA01, clofazimine, The metabolism of Clopidogrel can be decreased when combined with Clofazimine.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Clopidogrel is combined with Tenecteplase.]
[B06AX04, mitapivat, The metabolism of Clopidogrel can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Clopidogrel.]
[L01EJ03, pacritinib, The metabolism of Clopidogrel can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Clomipramine resulting in a loss in efficacy.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Clopidogrel.]
[C01EB24, mavacamten, The serum concentration of Clopidogrel can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Vonoprazan.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be decreased when combined with Clopidogrel.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Clopidogrel.]
[N05AH02, clozapine, The metabolism of Clopidogrel can be decreased when combined with Clozapine.]
[H01AC08, somatrogon, The metabolism of Clopidogrel can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Clopidogrel can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of bleeding can be increased when Proquazone is combined with Clopidogrel.]
[R05DA04, codeine, Codeine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA13, leflunomide, The serum concentration of Clopidogrel can be decreased when it is combined with Leflunomide.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Clopidogrel.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of bleeding can be increased when Imidazole salicylate is combined with Clopidogrel.]
[L01BB07, nelarabine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Nelarabine.]
[J01FA15, telithromycin, The metabolism of Clopidogrel can be decreased when combined with Telithromycin.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Indobufen is combined with Clopidogrel.]
[M01AH03, valdecoxib, The risk or severity of bleeding can be increased when Valdecoxib is combined with Clopidogrel.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Clopidogrel.]
[M01AH04, parecoxib, The risk or severity of bleeding can be increased when Parecoxib is combined with Clopidogrel.]
[J02AC02, itraconazole, The metabolism of Clopidogrel can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Bemiparin.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Clopidogrel.]
[M01AA06, kebuzone, The risk or severity of bleeding can be increased when Kebuzone is combined with Clopidogrel.]
[L01EA01, imatinib, The metabolism of Imatinib can be decreased when combined with Clopidogrel.]
[J02AC04, posaconazole, The metabolism of Clopidogrel can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Esomeprazole resulting in a loss in efficacy.]
[C08CA09, lacidipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Lacidipine.]
[S01BA03, cortisone, The metabolism of Clopidogrel can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Clopidogrel.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be decreased when combined with Clopidogrel.]
[M01AB09, lonazolac, The risk or severity of bleeding can be increased when Lonazolac is combined with Clopidogrel.]
[M02AA31, loxoprofen, The risk or severity of bleeding can be increased when Loxoprofen is combined with Clopidogrel.]
[C08CA11, manidipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Manidipine.]
[H02AB15, meprednisone, The metabolism of Clopidogrel can be increased when combined with Meprednisone.]
[C04AX01, cyclandelate, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Cyclandelate.]
[R06AE03, cyclizine, The metabolism of Clopidogrel can be decreased when combined with Cyclizine.]
[C03DA04, eplerenone, The metabolism of Clopidogrel can be decreased when combined with Eplerenone.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Clopidogrel.]
[N06AX07, minaprine, The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Clopidogrel.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Clopidogrel.]
[N06AG02, moclobemide, The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Clopidogrel.]
[N06BA07, modafinil, The metabolism of Clopidogrel can be decreased when combined with Modafinil.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Clopidogrel.]
[M02AA02, mofebutazone, The risk or severity of bleeding can be increased when Mofebutazone is combined with Clopidogrel.]
[M01AX22, morniflumate, The risk or severity of bleeding can be increased when Morniflumate is combined with Clopidogrel.]
[C03XA02, conivaptan, The metabolism of Clopidogrel can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Clopidogrel can be decreased when combined with Entecavir.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Clopidogrel.]
[M01AH05, etoricoxib, The risk or severity of bleeding can be increased when Etoricoxib is combined with Clopidogrel.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Clopidogrel.]
[L01DA01, dactinomycin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Dactinomycin.]
[G03XA01, danazol, The metabolism of Clopidogrel can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Clopidogrel.]
[L01DB02, daunorubicin, The metabolism of Clopidogrel can be increased when combined with Daunorubicin.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Clopidogrel.]
[M01AX01, nabumetone, The risk or severity of bleeding can be increased when Nabumetone is combined with Clopidogrel.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Clopidogrel.]
[N06AX06, nefazodone, The metabolism of Clopidogrel can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Clopidogrel can be decreased when combined with Nilutamide.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Clopidogrel.]
[R05DA06, normethadone, Normethadone can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B01AX05, fondaparinux, The risk or severity of bleeding can be increased when Clopidogrel is combined with Fondaparinux.]
[N06AB10, escitalopram, The risk or severity of bleeding can be increased when Escitalopram is combined with Clopidogrel.]
[A07EC03, olsalazine, The risk or severity of bleeding can be increased when Olsalazine is combined with Clopidogrel.]
[N06AA01, desipramine, The metabolism of Clopidogrel can be decreased when combined with Desipramine.]
[L01XA03, oxaliplatin, The serum concentration of Oxaliplatin can be increased when it is combined with Clopidogrel.]
[M01AE12, oxaprozin, The risk or severity of bleeding can be increased when Oxaprozin is combined with Clopidogrel.]
[N03AF02, oxcarbazepine, The metabolism of Clopidogrel can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Clopidogrel can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Clopidogrel.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Clopidogrel.]
[L04AB04, adalimumab, The metabolism of Clopidogrel can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Clopidogrel can be decreased when combined with Gefitinib.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Clopidogrel.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Clopidogrel.]
[N02AC01, dextromoramide, Dextromoramide can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AB05, paroxetine, The risk or severity of hemorrhage can be increased when Paroxetine is combined with Clopidogrel.]
[S01AA13, fusidic acid, The metabolism of Clopidogrel can be decreased when combined with Fusidic acid.]
[J01MB04, pipemidic acid, The metabolism of Clopidogrel can be decreased when combined with Pipemidic acid.]
[M01AG01, mefenamic acid, The risk or severity of bleeding can be increased when Mefenamic acid is combined with Clopidogrel.]
[N07BC06, heroin, Diamorphine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Clopidogrel.]
[S01BC03, diclofenac, The risk or severity of bleeding can be increased when Diclofenac is combined with Clopidogrel.]
[A03AX04, pinaverium, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Pinaverium.]
[A10BG03, pioglitazone, The serum concentration of Pioglitazone can be increased when it is combined with Clopidogrel.]
[L01DC04, ixabepilone, The risk or severity of bleeding can be increased when Clopidogrel is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Clopidogrel.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be decreased when combined with Clopidogrel.]
[C08CA03, isradipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Clopidogrel can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of bleeding can be increased when Diflunisal is combined with Clopidogrel.]
[C02DB01, dihydralazine, The metabolism of Clopidogrel can be decreased when combined with Dihydralazine.]
[N02AA03, hydromorphone, Hydromorphone can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AX04, lenalidomide, The risk or severity of bleeding can be increased when Clopidogrel is combined with Lenalidomide.]
[J05AE08, atazanavir, The metabolism of Clopidogrel can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The serum concentration of Treprostinil can be increased when it is combined with Clopidogrel.]
[C08DB01, diltiazem, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Diltiazem.]
[M02AX03, dimethyl sulfoxide, The metabolism of Clopidogrel can be decreased when combined with Dimethyl sulfoxide.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Clopidogrel.]
[N02BB04, propyphenazone, The risk or severity of bleeding can be increased when Propyphenazone is combined with Clopidogrel.]
[M01AB14, proglumetacin, The risk or severity of bleeding can be increased when Proglumetacin is combined with Clopidogrel.]
[C05CA03, diosmin, The metabolism of Clopidogrel can be decreased when combined with Diosmin.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Clopidogrel.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Clopidogrel.]
[A07DA01, diphenoxylate, Diphenoxylate can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CD10, quazepam, The metabolism of Clopidogrel can be decreased when combined with Quazepam.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Clopidogrel is combined with Dipyridamole.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Clopidogrel is combined with Drotrecogin alfa.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Clopidogrel.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Clopidogrel.]
[C01BA03, disopyramide, The metabolism of Clopidogrel can be decreased when combined with Disopyramide.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Clopidogrel.]
[S02AA12, rifamycin SV, The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifamycin.]
[J04AB05, rifapentine, The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifapentine.]
[D06AX11, rifaximin, The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifaximin.]
[N07XX02, riluzole, The metabolism of Clopidogrel can be decreased when combined with Riluzole.]
[N05AX08, risperidone, The metabolism of Clopidogrel can be decreased when combined with Risperidone.]
[N01BB09, ropivacaine, The metabolism of Clopidogrel can be decreased when combined with Ropivacaine.]
[J01MB01, rosoxacin, The metabolism of Clopidogrel can be decreased when combined with Rosoxacin.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Clopidogrel.]
[A04AD12, aprepitant, The metabolism of Clopidogrel can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The metabolism of Clopidogrel can be decreased when combined with Bortezomib.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be decreased when combined with Clopidogrel.]
[S01BC05, ketorolac, The risk or severity of bleeding can be increased when Ketorolac is combined with Clopidogrel.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Clopidogrel.]
[N02BA06, salsalate, The risk or severity of bleeding can be increased when Salsalate is combined with Clopidogrel.]
[R03AC12, salmeterol, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Clopidogrel.]
[C01CA04, dopamine, The serum concentration of Dopamine can be increased when it is combined with Clopidogrel.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Clopidogrel.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Clopidogrel.]
[L01DB01, doxorubicin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Doxorubicin.]
[N06AB06, sertraline, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Sertraline resulting in a loss in efficacy.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Clopidogrel.]
[A08AA10, sibutramine, The risk or severity of hemorrhage can be increased when Sibutramine is combined with Clopidogrel.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Clopidogrel.]
[J01MA05, temafloxacin, The metabolism of Clopidogrel can be decreased when combined with Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of bleeding can be increased when Clopidogrel is combined with Temozolomide.]
[M01AC02, tenoxicam, The risk or severity of bleeding can be increased when Tenoxicam is combined with Clopidogrel.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Clopidogrel.]
[G04BD05, terodiline, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Terodiline.]
[M01AG02, tolfenamic acid, The risk or severity of bleeding can be increased when Tolfenamic acid is combined with Clopidogrel.]
[N06AG03, toloxatone, The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Clopidogrel.]
[N03AX11, topiramate, The metabolism of Clopidogrel can be decreased when combined with Topiramate.]
[C03CA04, torsemide, The metabolism of Torasemide can be decreased when combined with Clopidogrel.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Clopidogrel is combined with Triflusal.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Troxerutin.]
[J01MA04, enoxacin, The metabolism of Clopidogrel can be decreased when combined with Enoxacin.]
[L01CA04, vinorelbine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Vinorelbine.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Clopidogrel.]
[N06AX16, venlafaxine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Venlafaxine.]
[S01GA03, xylometazoline, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Xylometazoline.]
[C08CA12, mepirodipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Barnidipine.]
[S01EA01, epinephrine, The serum concentration of Epinephrine can be increased when it is combined with Clopidogrel.]
[L01DB03, epirubicin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Epirubicin.]
[N05CF02, zolpidem, The metabolism of Clopidogrel can be decreased when combined with Zolpidem.]
[M01AB04, zomepirac, The risk or severity of bleeding can be increased when Zomepirac is combined with Clopidogrel.]
[N03AX15, zonisamide, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Zonisamide.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Clopidogrel.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Clopidogrel.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Clopidogrel is combined with Anistreplase.]
[L01XA02, carboplatin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Carboplatin.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Guanfacine.]
[B01AC11, iloprost, Iloprost may increase the antiplatelet activities of Clopidogrel.]
[N02CA02, ergotamine, The metabolism of Clopidogrel can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Clopidogrel can be decreased when combined with Erythromycin.]
[A02BC02, pantoprazole, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Pantoprazole resulting in a loss in efficacy.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Clopidogrel.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Clopidogrel.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Clopidogrel can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, The metabolism of Clopidogrel can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Clopidogrel can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Clopidogrel can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Clopidogrel.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Clopidogrel.]
[N03AD01, ethosuximide, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Ethosuximide.]
[M01AC06, meloxicam, The risk or severity of bleeding can be increased when Meloxicam is combined with Clopidogrel.]
[S01XA06, ethylmorphine, Ethylmorphine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Clopidogrel.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Clopidogrel.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Clopidogrel.]
[R06AX12, terfenadine, The metabolism of Clopidogrel can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Clopidogrel.]
[N06AB08, fluvoxamine, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Fluvoxamine resulting in a loss in efficacy.]
[C01BB03, tocainide, The metabolism of Tocainide can be decreased when combined with Clopidogrel.]
[B05AA05, dextran, The risk or severity of bleeding can be increased when Clopidogrel is combined with Dextran.]
[V03AF02, dexrazoxane, The risk or severity of bleeding can be increased when Clopidogrel is combined with Dexrazoxane.]
[A02BA03, famotidine, The metabolism of Clopidogrel can be decreased when combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Clopidogrel can be increased when combined with Albendazole.]
[C08CA02, felodipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Felodipine.]
[C08EA01, fendiline, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Fendiline.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Clopidogrel.]
[M01AE04, fenoprofen, The risk or severity of bleeding can be increased when Fenoprofen is combined with Clopidogrel.]
[N02AB03, fentanyl, Fentanyl can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Fibrinolysin.]
[L01BB06, clofarabine, The serum concentration of Clofarabine can be increased when it is combined with Clopidogrel.]
[L04AA40, cladribine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Cladribine.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Clopidogrel.]
[N02BG04, floctafenine, The risk or severity of bleeding can be increased when Floctafenine is combined with Clopidogrel.]
[J02AC01, fluconazole, The metabolism of Clopidogrel can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Flucytosine.]
[N07CA03, flunarizine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Clopidogrel.]
[D07AC08, fluocinonide, The metabolism of Clopidogrel can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Clopidogrel can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Clopidogrel can be decreased when combined with Ethanol.]
[L01BC09, floxuridine, The metabolism of Clopidogrel can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Clopidogrel.]
[N06AB03, fluoxetine, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Fluoxetine resulting in a loss in efficacy.]
[S01BC04, flurbiprofen, The risk or severity of bleeding can be increased when Flurbiprofen is combined with Clopidogrel.]
[N05AG01, fluspirilene, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Fluspirilene.]
[L02BB01, flutamide, The metabolism of Clopidogrel can be decreased when combined with Flutamide.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Clopidogrel.]
[G01AX06, furazolidone, The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Clopidogrel.]
[J05AE10, darunavir, The metabolism of Clopidogrel can be decreased when combined with Darunavir.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Clopidogrel.]
[C08DA02, gallopamil, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Gallopamil.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Ganciclovir.]
[C10AB04, gemfibrozil, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Gemfibrozil resulting in a loss in efficacy.]
[L01EA02, dasatinib, Dasatinib may increase the anticoagulant activities of Clopidogrel.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Clopidogrel.]
[J05AG04, etravirine, The metabolism of Clopidogrel can be decreased when combined with Etravirine.]
[N03AD03, methsuximide, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Methsuximide.]
[N01AH02, alfentanil, Alfentanil can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Clopidogrel.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Clopidogrel.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Clopidogrel.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Clopidogrel.]
[M01AX05, glucosamine, Glucosamine may increase the antiplatelet activities of Clopidogrel.]
[N05CM18, dexmedetomidine, The metabolism of Clopidogrel can be decreased when combined with Dexmedetomidine.]
[C01BD04, dofetilide, The serum concentration of Dofetilide can be increased when it is combined with Clopidogrel.]
[C02CA04, doxazosin, The metabolism of Clopidogrel can be decreased when combined with Doxazosin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Clopidogrel.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Clopidogrel is combined with Fluindione.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Clopidogrel.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Clopidogrel.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Clopidogrel.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Clopidogrel.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Clopidogrel.]
[C09CA01, losartan, The metabolism of Clopidogrel can be decreased when combined with Losartan.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Heparin.]
[A07EC02, mesalamine, The risk or severity of bleeding can be increased when Mesalazine is combined with Clopidogrel.]
[L01XX03, altretamine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Altretamine.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Clopidogrel.]
[J05AG01, nevirapine, The metabolism of Clopidogrel can be increased when combined with Nevirapine.]
[C08CA10, nilvadipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nilvadipine.]
[M02AA26, nimesulide, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nimesulide.]
[R05DA03, hydrocodone, Hydrocodone can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S02BA01, hydrocortisone, The metabolism of Clopidogrel can be increased when combined with Hydrocortisone.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Clopidogrel.]
[L01XX05, hydroxyurea, The risk or severity of bleeding can be increased when Clopidogrel is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, The metabolism of Clopidogrel can be decreased when combined with Hydroxyzine.]
[J04AB04, rifabutin, The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifabutin.]
[R02AX02, ibuprofen, The risk or severity of bleeding can be increased when Ibuprofen is combined with Clopidogrel.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Clopidogrel is combined with Sodium citrate.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Clopidogrel.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Clopidogrel.]
[H01AC02, somatrem, The metabolism of Clopidogrel can be increased when combined with Somatrem.]
[N01AH03, sufentanil, Sufentanil can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AA02, imipramine, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Imipramine resulting in a loss in efficacy.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Clopidogrel.]
[M03BX02, tizanidine, The metabolism of Clopidogrel can be decreased when combined with Tizanidine.]
[L01CE01, topotecan, The risk or severity of bleeding can be increased when Clopidogrel is combined with Topotecan.]
[S01BC01, indomethacin, The risk or severity of bleeding can be increased when Indomethacin is combined with Clopidogrel.]
[L03AB04, interferon alfa-2a, The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-2b.]
[N06AX17, milnacipran, The metabolism of Clopidogrel can be decreased when combined with Milnacipran.]
[S01XA28, varenicline, The excretion of Varenicline can be decreased when combined with Clopidogrel.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be decreased when combined with Clopidogrel.]
[N05BA12, alprazolam, The metabolism of Clopidogrel can be decreased when combined with Alprazolam.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Clopidogrel.]
[C10AA06, cerivastatin, The serum concentration of Cerivastatin can be increased when it is combined with Clopidogrel.]
[L01XX35, anagrelide, Anagrelide may increase the antiplatelet activities of Clopidogrel.]
[L03AB09, interferon alfacon-1, The metabolism of Clopidogrel can be decreased when combined with Interferon alfacon-1.]
[N06AF05, iproniazid, The metabolism of Clopidogrel can be decreased when combined with Iproniazid.]
[J05AB13, penciclovir, The metabolism of Clopidogrel can be decreased when combined with Penciclovir.]
[N06AF01, isocarboxazid, The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Clopidogrel.]
[P01AX06, atovaquone, The metabolism of Clopidogrel can be decreased when combined with Atovaquone.]
[N01AB06, isoflurane, The metabolism of Isoflurane can be decreased when combined with Clopidogrel.]
[J04AC01, isoniazid, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Isoniazid resulting in a loss in efficacy.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Bivalirudin.]
[H01AC01, somatropin, The metabolism of Clopidogrel can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Clopidogrel can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Clopidogrel.]
[C02KD01, ketanserin, Clopidogrel may increase the antiplatelet activities of Ketanserin.]
[B01AC22, prasugrel, The risk or severity of bleeding can be increased when Clopidogrel is combined with Prasugrel.]
[J02AB02, ketoconazole, The metabolism of Clopidogrel can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Clopidogrel can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of bleeding can be increased when Ketoprofen is combined with Clopidogrel.]
[V03AC03, deferasirox, The serum concentration of Clopidogrel can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Clopidogrel can be increased when combined with Abatacept.]
[J01MB02, nalidixic acid, The metabolism of Clopidogrel can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of bleeding can be increased when Tiaprofenic acid is combined with Clopidogrel.]
[C07AG01, labetalol, The metabolism of Clopidogrel can be decreased when combined with Labetalol.]
[N04BB01, amantadine, The serum concentration of Amantadine can be increased when it is combined with Clopidogrel.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Clopidogrel.]
[L01DC03, mitomycin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Mitomycin.]
[G03AD01, levonorgestrel, The metabolism of Clopidogrel can be decreased when combined with Levonorgestrel.]
[S02DA01, lidocaine, The metabolism of Clopidogrel can be decreased when combined with Lidocaine.]
[C08EX01, lidoflazine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Lidoflazine.]
[N06BA13, armodafinil, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Armodafinil resulting in a loss in efficacy.]
[L01AD02, lomustine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Lomustine.]
[A07DA03, loperamide, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Loperamide.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Clopidogrel.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Clopidogrel.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Clopidogrel.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Clopidogrel can be decreased when combined with Nilotinib.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Clopidogrel.]
[L01AA05, mechlorethamine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Clopidogrel.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Dalteparin.]
[N05CH01, melatonin, The metabolism of Melatonin can be decreased when combined with Clopidogrel.]
[L01AA03, melphalan, The risk or severity of bleeding can be increased when Clopidogrel is combined with Melphalan.]
[N06DX01, memantine, The metabolism of Clopidogrel can be decreased when combined with Memantine.]
[N02AB02, meperidine, Meperidine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Clopidogrel.]
[N03AA01, mephobarbital, The metabolism of Methylphenobarbital can be decreased when combined with Clopidogrel.]
[N02AX05, meptazinol, Meptazinol can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Clopidogrel.]
[A10BA02, metformin, The serum concentration of Metformin can be increased when it is combined with Clopidogrel.]
[N07BC02, methadone, Methadone can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AF05, lamivudine, The serum concentration of Lamivudine can be increased when it is combined with Clopidogrel.]
[H03BB02, methimazole, The metabolism of Clopidogrel can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The metabolism of Clopidogrel can be decreased when combined with Pemetrexed.]
[N02BG08, ziconotide, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Ziconotide.]
[L04AX03, methotrexate, The risk or severity of bleeding can be increased when Clopidogrel is combined with Methotrexate.]
[D05BA02, methoxsalen, The metabolism of Clopidogrel can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Clopidogrel.]
[V04CG05, methylene blue, The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Clopidogrel.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Clopidogrel.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be decreased when combined with Clopidogrel.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Clopidogrel.]
[P01AB01, metronidazole, The metabolism of Clopidogrel can be decreased when combined with Metronidazole.]
[C01BB02, mexiletine, The metabolism of Clopidogrel can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Clopidogrel.]
[S02AA13, miconazole, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Miconazole resulting in a loss in efficacy.]
[N02BB03, aminopyrine, The risk or severity of bleeding can be increased when Aminophenazone is combined with Clopidogrel.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Parnaparin.]
[N05CD08, midazolam, The metabolism of Clopidogrel can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Clopidogrel can be decreased when combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Tinzaparin.]
[C09CA03, valsartan, The metabolism of Clopidogrel can be decreased when combined with Valsartan.]
[L01XX23, mitotane, The metabolism of Clopidogrel can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of bleeding can be increased when Clopidogrel is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Aldesleukin.]
[C01BD01, amiodarone, The risk or severity of bleeding can be increased when Amiodarone is combined with Clopidogrel.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Clopidogrel.]
[N02AA01, morphine, The serum concentration of the active metabolites of Clopidogrel can be decreased when Clopidogrel is used in combination with Morphine.]
[L04AB05, certolizumab pegol, The metabolism of Clopidogrel can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Clopidogrel.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Clopidogrel.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be decreased when combined with Clopidogrel.]
[G03XC01, raloxifene, The metabolism of Clopidogrel can be decreased when combined with Raloxifene.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Clopidogrel.]
[L03AB08, interferon beta-1b, The metabolism of Clopidogrel can be decreased when combined with Interferon beta-1b.]
[J01CF06, nafcillin, The metabolism of Clopidogrel can be increased when combined with Nafcillin.]
[N02AF02, nalbuphine, Nalbuphine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V03AB15, naloxone, The metabolism of Clopidogrel can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, Naltrexone can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC03, anakinra, The metabolism of Clopidogrel can be increased when combined with Anakinra.]
[M02AA12, naproxen, The risk or severity of bleeding can be increased when Naproxen is combined with Clopidogrel.]
[A10BG01, troglitazone, The metabolism of Troglitazone can be decreased when combined with Clopidogrel.]
[N06AX21, duloxetine, The risk or severity of hemorrhage can be increased when Duloxetine is combined with Clopidogrel.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Clopidogrel.]
[L02BG04, letrozole, The metabolism of Clopidogrel can be decreased when combined with Letrozole.]
[N01AH06, remifentanil, Remifentanil can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10BX02, repaglinide, The risk or severity of hypoglycemia can be increased when Clopidogrel is combined with Repaglinide.]
[B01AC17, tirofiban, Clopidogrel may increase the antiplatelet activities of Tirofiban.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Clopidogrel.]
[N06AX23, desvenlafaxine, The metabolism of Clopidogrel can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, The metabolism of Clopidogrel can be decreased when combined with Telmisartan.]
[L01XX01, amsacrine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Amsacrine.]
[N06AF02, nialamide, The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Clopidogrel.]
[C08CA04, nicardipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Clopidogrel can be decreased when combined with Niclosamide.]
[N07BA01, nicotine, The metabolism of Nicotine can be decreased when combined with Clopidogrel.]
[C08CA05, nifedipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of bleeding can be increased when Niflumic acid is combined with Clopidogrel.]
[C08CA06, nimodipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nimodipine.]
[C08CA07, nisoldipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nisoldipine.]
[C08CA08, nitrendipine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nitrendipine.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Clopidogrel.]
[N04BC05, pramipexole, The serum concentration of Pramipexole can be increased when it is combined with Clopidogrel.]
[C01CA03, norepinephrine, The serum concentration of Norepinephrine can be increased when it is combined with Clopidogrel.]
[G03DC02, norethindrone, The metabolism of Clopidogrel can be decreased when combined with Norethisterone.]
[S01AE02, norfloxacin, The metabolism of Clopidogrel can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, The metabolism of Clopidogrel can be increased when combined with Bosentan.]
[R05DA07, noscapine, The metabolism of Clopidogrel can be decreased when combined with Noscapine.]
[B01AC16, eptifibatide, Eptifibatide may increase the antiplatelet activities of Clopidogrel.]
[L03AB07, interferon beta-1a, The metabolism of Clopidogrel can be decreased when combined with Interferon beta-1a.]
[G02CA02, nylidrin, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nylidrin.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Reviparin.]
[L04AC04, rilonacept, The metabolism of Clopidogrel can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Omeprazole resulting in a loss in efficacy.]
[N02AA02, opium, Opium can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Clopidogrel is combined with Reteplase.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Clopidogrel is combined with Ancrod.]
[A14AA08, oxandrolone, The metabolism of Clopidogrel can be decreased when combined with Oxandrolone.]
[N02AA05, oxycodone, Oxycodone can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02AA11, oxymorphone, Oxymorphone can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01BC02, oxyphenbutazone, The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Clopidogrel.]
[J04AA01, aminosalicylic acid, The risk or severity of bleeding can be increased when Clopidogrel is combined with Aminosalicylic acid.]
[N05AH05, asenapine, The metabolism of Asenapine can be decreased when combined with Clopidogrel.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Clopidogrel is combined with Danaparoid.]
[N02AX06, tapentadol, Tapentadol can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Pancuronium.]
[H02AB05, paramethasone, The metabolism of Clopidogrel can be increased when combined with Paramethasone.]
[C02KC01, pargyline, The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Clopidogrel.]
[J01MA03, pefloxacin, The metabolism of Clopidogrel can be decreased when combined with Pefloxacin.]
[N05AG03, penfluridol, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Penfluridol.]
[M01CC01, penicillamine, The risk or severity of bleeding can be increased when Clopidogrel is combined with Penicillamine.]
[N02AD01, pentazocine, Pentazocine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CA01, pentobarbital, The metabolism of Clopidogrel can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of bleeding can be increased when Clopidogrel is combined with Pentostatin.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the antiplatelet activities of Clopidogrel.]
[C08EX02, perhexiline, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Perhexiline.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Clopidogrel.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Clopidogrel.]
[N02AD02, phenazocine, Phenazocine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AF03, phenelzine, The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Clopidogrel.]
[A10BA01, phenformin, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Phenformin.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Clopidogrel is combined with Phenindione.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Clopidogrel.]
[N01AH04, phenoperidine, Phenoperidine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Clopidogrel is combined with Phenprocoumon.]
[M02AA01, phenylbutazone, The risk or severity of bleeding can be increased when Phenylbutazone is combined with Clopidogrel.]
[S01GA05, phenylephrine, The metabolism of Clopidogrel can be increased when combined with Phenylephrine.]
[A02BC06, dexlansoprazole, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Dexlansoprazole resulting in a loss in efficacy.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Clopidogrel.]
[L04AB06, golimumab, The metabolism of Clopidogrel can be increased when combined with Golimumab.]
[C08CX01, mibefradil, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Clopidogrel.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Clopidogrel.]
[J05AE01, saquinavir, The metabolism of Clopidogrel can be decreased when combined with Saquinavir.]
[N02AC03, pirinitramide, Piritramide can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01BC06, piroxicam, The risk or severity of bleeding can be increased when Piroxicam is combined with Clopidogrel.]
[J01MA11, grepafloxacin, The metabolism of Clopidogrel can be decreased when combined with Grepafloxacin.]
[J05AG02, delavirdine, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Delavirdine resulting in a loss in efficacy.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Clopidogrel.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Clopidogrel is combined with Abciximab.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Clopidogrel.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Clopidogrel is combined with Alteplase.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be decreased when combined with Clopidogrel.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Clopidogrel.]
[A03AE01, alosetron, The metabolism of Clopidogrel can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Clopidogrel can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Clopidogrel can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Clopidogrel.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Clopidogrel.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Clopidogrel.]
[C02CA01, prazosin, The serum concentration of Prazosin can be increased when it is combined with Clopidogrel.]
[C01DX02, prenylamine, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Prenylamine.]
[P01BA03, primaquine, The metabolism of Clopidogrel can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Clopidogrel can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Clopidogrel can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The serum concentration of Procainamide can be increased when it is combined with Clopidogrel.]
[S01HA05, procaine, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Clopidogrel.]
[L01XB01, procarbazine, The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Clopidogrel.]
[C10AB05, fenofibrate, The metabolism of Clopidogrel can be decreased when combined with Fenofibrate.]
[G03DA04, progesterone, The metabolism of Clopidogrel can be decreased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Clopidogrel can be decreased when combined with Promazine.]
[R06AD02, promethazine, The metabolism of Promethazine can be decreased when combined with Clopidogrel.]
[C01BC03, propafenone, The metabolism of Clopidogrel can be decreased when combined with Propafenone.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Clopidogrel.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Clopidogrel.]
[N02AC04, propoxyphene, Dextropropoxyphene can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C07AA05, propranolol, The metabolism of Clopidogrel can be decreased when combined with Propranolol.]
[H03BA02, propylthiouracil, The risk or severity of bleeding can be increased when Clopidogrel is combined with Propylthiouracil.]
[B01AC09, epoprostenol, The risk or severity of bleeding can be increased when Clopidogrel is combined with Epoprostenol.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Clopidogrel.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Clopidogrel.]
[N07XX07, dalfampridine, The serum concentration of Dalfampridine can be increased when it is combined with Clopidogrel.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Clopidogrel.]
[C01BA01, quinidine, The metabolism of Clopidogrel can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Quinine can be decreased when combined with Clopidogrel.]
[A02BA02, ranitidine, The serum concentration of Ranitidine can be increased when it is combined with Clopidogrel.]
[C02AA02, reserpine, The serum concentration of Reserpine can be increased when it is combined with Clopidogrel.]
[J04AB02, rifampin, The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifampicin.]
[N02BA05, salicylamide, The risk or severity of bleeding can be increased when Salicylamide is combined with Clopidogrel.]
[A07EC01, sulfasalazine, The risk or severity of bleeding can be increased when Sulfasalazine is combined with Clopidogrel.]
[S01BC08, salicylic acid, The risk or severity of bleeding can be increased when Salicylic acid is combined with Clopidogrel.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Clopidogrel.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Obinutuzumab.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Clopidogrel.]
[N03AG01, valproic acid, The metabolism of Clopidogrel can be decreased when combined with Valproic acid.]
[A05AA01, chenodeoxycholic acid, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Chenodeoxycholic acid.]
[D11AX24, deoxycholic acid, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Deoxycholic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Clopidogrel.]
[H02CA04, levoketoconazole, The metabolism of Clopidogrel can be decreased when combined with Levoketoconazole.]
[A05AA02, ursodiol, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Ursodeoxycholic acid.]
